Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

PCN Insights, News, Videos, and More

News
09/24/2021
Tom Valentino, Senior Editor
DemeRx, a Miami-based atai Life Sciences platform company that is developing ibogaine for the treatment of opioid use disorder, announced that the first subjects have been dosed in its Phase 1/2a clinical trial of ibogaine HCl (DMX-1002), an...
DemeRx, a Miami-based atai Life Sciences platform company that is developing ibogaine for the treatment of opioid use disorder, announced that the first subjects have been dosed in its Phase 1/2a clinical trial of ibogaine HCl (DMX-1002), an...
DemeRx, a Miami-based atai Life...
09/24/2021
Psych Congress Network
Dr Maletic
Podcasts
09/23/2021
In this podcast, Vladimir Maletic, MD, MS, Clinical Professor of Psychiatry, University of South Carolina School of Medicine, Greenville, discusses the risks associated with comorbid conditions in patients with attention deficit/hyperactivity...
In this podcast, Vladimir Maletic, MD, MS, Clinical Professor of Psychiatry, University of South Carolina School of Medicine, Greenville, discusses the risks associated with comorbid conditions in patients with attention deficit/hyperactivity...
In this podcast, Vladimir...
09/23/2021
Psych Congress Network
News
09/22/2021
Psychological interventions for subthreshold depression appear to have positive acute effects in adolescents, according to a meta-analysis published in the Journal of the American Academy of Child and Adolescent Psychiatry.
Psychological interventions for subthreshold depression appear to have positive acute effects in adolescents, according to a meta-analysis published in the Journal of the American Academy of Child and Adolescent Psychiatry.
Psychological interventions for...
09/22/2021
Psych Congress Network
News
09/22/2021
Jolynn Tumolo
Adaptive Testing Technologies recently launched a computerized adaptive test that quickly assesses a young person’s likelihood of attempting suicide. Read on to learn about how CASSY can help your patients.
Adaptive Testing Technologies recently launched a computerized adaptive test that quickly assesses a young person’s likelihood of attempting suicide. Read on to learn about how CASSY can help your patients.
Adaptive Testing Technologies...
09/22/2021
Psych Congress Network
News
09/22/2021
Erin McGuinness
Severe symptoms of premenstrual dysphoric disorder are linked to increased severity of symptoms and illness course for patients with bipolar disorder, according to a recent literature review published in Frontiers in Psychiatry
Severe symptoms of premenstrual dysphoric disorder are linked to increased severity of symptoms and illness course for patients with bipolar disorder, according to a recent literature review published in Frontiers in Psychiatry
Severe symptoms of premenstrual...
09/22/2021
Psych Congress Network
Sanjai Rao, University of California
Videos
09/21/2021
In this video, Sanjai Rao, MD, DFAPA, explains the pharmacologic properties of long-acting injectables (LAIs) and how this treatment option impacts patient preferences.
In this video, Sanjai Rao, MD, DFAPA, explains the pharmacologic properties of long-acting injectables (LAIs) and how this treatment option impacts patient preferences.
In this video, Sanjai Rao, MD,...
09/21/2021
Psych Congress Network
News
09/19/2021
Meagan Thistle
This weekend’s 3-day Inaugural Sana Symposium guided virtual attendees through the preparation, journey, and integration of psychedelic therapies.
This weekend’s 3-day Inaugural Sana Symposium guided virtual attendees through the preparation, journey, and integration of psychedelic therapies.
This weekend’s 3-day Inaugural...
09/19/2021
Psych Congress Network
News
09/19/2021
Tom Valentino, Senior Editor
As public interest in psychedelics builds, practitioners must be ready to chart a path forward that balances helping patients while protecting both those patients and clinicians themselves, Saundra Jain, MA, PsyD, LPC, told Sana Symposium...
As public interest in psychedelics builds, practitioners must be ready to chart a path forward that balances helping patients while protecting both those patients and clinicians themselves, Saundra Jain, MA, PsyD, LPC, told Sana Symposium...
As public interest in...
09/19/2021
Psych Congress Network
News
09/19/2021
Erin McGuinness
Rick Doblin, PhD, Founder and Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS), Belmont, Massachusetts, discussed the possible future treatment landscape for psychedelics under legalization during a virtual...
Rick Doblin, PhD, Founder and Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS), Belmont, Massachusetts, discussed the possible future treatment landscape for psychedelics under legalization during a virtual...
Rick Doblin, PhD, Founder and...
09/19/2021
Psych Congress Network
News
09/18/2021
Erin McGuinness
Rosalind Watts, PhD, Clinical Director, Synthesis Institute, London, England, discussed the therapeutic relationship in psilocybin treatment for depression during a virtual presentation at Sana Symposium.
Rosalind Watts, PhD, Clinical Director, Synthesis Institute, London, England, discussed the therapeutic relationship in psilocybin treatment for depression during a virtual presentation at Sana Symposium.
Rosalind Watts, PhD, Clinical...
09/18/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement